Skip to main content

A Prooxidant Mechanism for the Anticancer and Chemopreventive Properties of Plant Polyphenols

Buy Article:

$68.00 + tax (Refund Policy)

Plant-derived polyphenols, a prominent class of phytochemicals, are considered important components of human diet. A number of them are known to possess chemopreventive and therapeutic properties against various diseases including cancer. Several studies using cancer cell lines and animal models of carcinogenesis have shown that a wide range of polyphenols possess anticancer and apoptosis-inducing properties. Notably, an important aspect of the chemopreventive action of polyphenols is their differential activity in selectively targeting cancer cells while sparing normal cells. However, the mechanism through which polyphenols modulate their cancer cell selective anticancer effects has not been clearly delineated. In this regard, identification of a definitive anticancer mechanism of polyphenols would contribute to establish them as potent lead compounds for the synthesis of novel anticancer drugs. Although polyphenols are generally recognized as antioxidants, they also act as prooxidants inducing DNA degradation in the presence of metal ions such as copper. Based on our own observations and those of others, a mechanism for the anticancer properties of polyphenols that involves mobilization of chromatin-bound copper and consequent prooxidant action leading to cell death, was proposed. Since it is known that tissue and cellular copper levels are significantly elevated in a number of malignancies, cancer cells would be more subject to redox cycling between copper ions and polyphenols to generate reactive oxygen species (ROS) responsible for DNA breakage. This review discusses such a copper-dependent prooxidant mechanism of action of polyphenols that accounts for their observed chemopreventive properties, as also for their preferential cytotoxicity towards cancer cells.

Keywords: Anticancer; DNA breakage; ROS; cancer chemoprevention; copper; polyphenols; prooxidant action

Document Type: Research Article

Publication date: 01 December 2012

More about this publication?
  • Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will be devoted to a single timely topic, with series of in-depth reviews, written by leaders in the field, covering a range of current topics on drug targets. These issues will be organized and led by a guest editor who is a recognized expert in the overall topic. As the discovery, identification, characterisation and validation of novel human drug targets for drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content